Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

Columnist Caroline Gainer sees nature as a "mood enhancement provider," stress reducer, and breathing aid in her life with ...

That’s according to data from a Phase 4 observational pilot study (NCT05241288) that followed 40 COPD patients with poor lung function and recurrent exacerbations. In the two weeks before an ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

Treatment of COPD with noninvasive ventilation (NIV) is effective in acute flares, in helping in pulmonary rehabilitation, and in managing high levels of carbon dioxide. According to the GOLD ...

GSP 304 (tiotropium bromide) is a mist that Glenmark Pharmaceuticals is developing to widen the narrowed airways that are a hallmark of chronic obstructive pulmonary disease.. Glenmark is working on U ...

Mary Chapman is an award-winning journalist who writes feature stories for COPD News Today. She covers the latest news and information on a variety of COPD topics.

Columnist Caroline Gainer had been searching for ways to improve her rest. Now, with help of her Fitbit, she's found her ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Chronic obstructive pulmonary disease, or COPD, is an inflammatory lung disease mainly caused by long-term exposure to irritants, such as cigarette smoke, air pollution, and chemical gases.In rare ...

The study, “E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research Program,” was published in Nicotine & Tobacco Research. COPD is a progressive, inflammatory lung condition ...